1000. Deputy Colm Burke asked the Minister for Health if consideration will be given to reviewing the rigorous statutory assessment arrangements in Ireland, regarding the reimbursement process for new cancer medicines, given the five-year net survival rate for all invasive cancers averaged 65% for cancer patients diagnosed between 2014 and 2018, which is in the middle and lower end of survival rates across all invasive cancers in the EU15 countries during the same time period, to improve survival rates and save additional lives of cancer patients going forward; and if he will make a statement on the matter. [54534/22]

Summary

1000. Deputy Colm Burke asked the Minister for Health if consideration will be given to reviewing the rigorous statutory assessment arrangements in Ireland, regarding the reimbursement process for new cancer medicines, given the five-year net survival rate for all invasive cancers averaged 65% for cancer patients diagnosed between 2014 and 2018, which is in the middle and lower end of survival rates across all invasive cancers in the EU15 countries during the same time period, to improve survival rates and save additional lives of cancer patients going forward; and if he will make a statement on the matter. [54534/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 8 November 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.